Preoperative Embolization of Intracranial Meningiomas with Embosphere® Microspheres

Abstract

Background: To reduce intraoperative bleeding and to facilitate surgery by inducing tumor softening, a preoperative embolization of meningiomas is commonly recommended.

Patients and Methods: We report on our experience with non-resorbable microspheres (Embosphere®) in the preoperative endovascular embolization of 17 intracranial meningiomas. After adding contrast media to the particles sized 40 - 500 micron, the embolization process was followed under fluoroscopy. There was a good passage of microcatheters if high concentrations of particles were avoided.

Results: The obstruction of the tumor feeders by particles was accompanied by a regression of tumor blush in DSA. CT controls showed a diminished contrast accumulation of the tumors already 1 - 2 days after embolization. Histologically, Embosphere® microspheres were easy detectable with all commonly used staining methods. Embolization triggered, microscopically detectable necrosis was found in 77 % of the tumors. The mean interval between embolization and tumor extirpation was 2.5 days. The average time required for tumor extirpation was 244 minutes, while the average blood loss was 749 ml.

Conclusions: Our experiences show that Embosphere® microspheres are effective embolic agents in obstructing meningeal feeders of preoperatively treated meningiomas.

Key words

Embosphere® (Trisacryl gelatine microspheres) - preoperative embolization of meningiomas - embolization with particles - histology of Embosphere® microspheres

References

• 1 Kai Y, Hamada J, Morioka M, Yano S, Todaka T, Ushio Y. Appropriate interval between embolization and surgery in patients with meningioma.  AJNR. 2002;  23 139-142
• 2 Chun J Y, McDermott M W, Lamborn K R, Wilson C B, Higashida R, Berger M S. Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas.  Neurosurgery. 2002;  50 1231-1235
• 3 Latchaw R E. Preoperative intracranial menigioma embolization: technical considerations affecting the risk-to-benefit ratio.  AJNR. 1993;  14 583-586
• 4 Nelson P K, Setton A, Choi I S, Ransohoff J, Berenstein A. Current status of interventional neuroradiology in the management of meningiomas.  Neurosurg Clin N Am. 1994;  5 235-259
• 5 Wakhloo A K, Juengling F D, Velthoven V van, Schuhmacher M, Hennig J, Schwechheimer K. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques.  AJNR. 1993;  14 571-582
• 6 Kallmes D F, Evans A J, Kaptain G J, Mathis J M, Jensen M E, Jane J A, Dion J E. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature.  Neuroradiology. 1997;  39 877-880
• 7 Kuroiwa T, Tanaka H, Ohta T, Tsutsumi A. Preoperative embolization of highly vascular brain tumors: clinical and histopathological findings.  Noshuyo Byori. 1996;  13 27-36
• 8 Tereda T, Kinoshita Y, Yokote H, Tsuura M, Itakura T, Komai N, Nakamura Y, Tanaka S, Kuriyama T. Preoperative embolization of meningiomas fed by ophthalmic branch arteries.  Surg Neurol. 1996;  45 161-166
• 9 Kaji T, Hama Y, Iwasaki Y, Kyoto Y, Kusano S. Preoperative embolization of meningiomas with pial supply: successful treatment of two cases.  Surg Neurol. 1999;  52 270-273
• 10 Probst E N, Grzyska U, Westphal M, Zeumer H. Preoperative embolization of intracranial meningiomas with a fibrin glue preparation.  AJNR. 1999;  20 1695-1702
• 11 Derdeyn C P, Moran C J, Cross T, Dietrich H H, Dacey R G. Polyvinyl alcohol particle size and suspension characteristics.  AJNR. 1995;  16 1335-1443
• 12 Laurent A, Beaujeux R, Wassef M, Rüfenacht D, Boschetti E, Merland J J. Trisacryl gelatin microspheres for therapeutic embolization, I: Development and in vitro evaluation.  AJNR. 1996;  17 533-540
• 13 Beaujeux R, Laurent A, Hodes J E, Wassef M, Merland J J. Calibrated sphere embolization of craniofacial tumours and arteriovenous malformations.  Neuroradiology. 1991;  33 (Suppl) 562-564
• 14 Derdeyn C P, Graves V B, Salamat M S, Rappe A. Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics.  AJNR. 1997;  18 647-653
• 15 Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin Y P, Aymard A, Rüfenacht D, Merland J J. Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evaluation in tumors and arteriovenous malformations.  AJNR. 1996;  17 541-548
• 16 Wein B B, Günther R W. Embolisation mit gelatine-imprägnierten Mikrosphären.  Fortschr Röntgenstr. 1998;  168 171-174
• 17 Eskridge J M. Interventional neuroradiology.  Radiology. 1989;  172 991-1005
• 18 Sellar R. New products.  Neurointerventionist. 2001;  2 74-78
• 19 Bendzus M, Martin-Schrader I, Schlake H P, Solymosi L. Embolisation of intracranial meningiomas without subsequent surgery.  Neuroradiology. 2003;  45 451-455
• 20 Bendzus M, Warmuth-Metz M, Klein R, Bartsch A J, Krone A, Tonn J C, Solymosi L. Sequential MRI and MR spectroscopy in embolized meningeomas: correlation with surgical and histopathological findings.  Neuroradiology. 2002;  44 77-82
• 21 Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas.  AJNR. 2000;  21 255-261